ResMed Inc.

Healthcare

NYSE:RMD · New York Stock Exchange

Market Cap $27.24B Beta 0.78 P/E (TTM) 18.1

$188.63 +0.85%

+$1.58 today

52W Low $180.27High $293.81

Vol 1.52M · Avg 1.32M

EPS (TTM) $10.37 Div Yield 1.28%Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-25.16%

Period High

$291.49

Period Low

$182.82

Latest

$188.63

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Cardinal Health, Inc.

NYSE:CAH

$52.33B

Becton, Dickinson and Company

NYSE:BDX

$52.14B

Humana Inc.

NYSE:HUM

$43.03B

Haleon plc

NYSE:HLN

$39.53B

Agilent Technologies, Inc.

NYSE:A

$35.92B

Alcon Inc.

NYSE:ALC

$31.54B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

$28.03B

IQVIA Holdings Inc.

NYSE:IQV

$27.96B

Mettler-Toledo International Inc.

NYSE:MTD

$23.13B

Insmed Incorporated

NASDAQ:INSM

$20.62B

What is the latest RMD filing?

The latest filing shown is 4 dated Jun 9, 2026.

How many recent filings does RMD have?

Intrinsic Alpha currently shows 20 recent filings for RMD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.